课题基金 / 基金详情

The pathophysiological significanse and mechanism of activation of key enzyme responsible for adenosine production in ischemic preconditioning.

The pathophysiological significanse and mechanism of activation of key enzyme responsible for adenosine production in ischemic preconditioning.
缺血预处理中负责腺苷产生的关键酶的病理生理意义和激活机制。
批准号:
07457171
负责人:
HORI Masatsugu
金额:
$4.8万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

HORI Masatsugu的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经报道了化学预适应(IP)中的心脏保护作用可归因于外5′-核苷酸酶(ecto-5′nt)的激活,外5′-核苷酸酶是犬心肌中负责腺苷产生的关键酶,并且外5′- nt被蛋白激酶C (PKC)激活。在开胸犬中,通过4次5分钟的冠状动脉闭塞产生IP,间隔5分钟。心肌外泌素-5′nt活性和腺苷释放增加,但外泌素-5′nt抑制剂(AMP-CP)使两者钝化。AMP-CP对梗死面积的限制作用也减弱。此外,短暂给予甲氧沙明(α 1-肾上腺素受体的刺激剂)和PMA (PKC的激活剂)4次,每次5分钟,间隔5分钟,模拟了IP后ecto-5'NT活性的增加和梗死面积的限制作用。接下来,我们验证了缺血预适应(IP)归因于α - pkc激活的假设。IP激活Ca^<2+>-依赖的PKC。免疫印迹(IB)显示,与对照心肌相比,α - pkc含量增加,但β -、δ -和epsilon-PKC含量不变。在相同的膜组分中,ecto-5'NT活性增加。然后,我们检测了PKC是否在犬预处理心肌中磷酸化外5′T。免疫沉淀的ecto-5'NT为IB,有抗磷酸化抗体。我们观察到免疫沉淀的ecto-5'NT的丝氨酸-茶氨酸磷酸化。此外,PKC和ecto-5'NT因IP而增加的活性被减弱,免疫沉淀的ecto-5'NT的丝氨酸-苏氨酸磷酸化未被GY109203X(蛋白激酶C的特异性抑制剂)检测到。我们得出结论,心肌中的ecto-5'NT被PKC磷酸化并激活,以增加腺苷的释放。体外5′nt磷酸化激活是心肌梗死的重要机制。少
英文摘要
We have reported that cardioprotection in is chemic preconditining (IP) is attributable to activation of ecto-5'-nucleotidase (ecto-5'NT), akey enzyme responsible for adenosine production in the canine myocadium, and that ecto-5'NT is activated by protein kinase C (PKC). In the open chest dogs, IP was produced by 4 times of 5-min coronary occlusion with a 5-min interval. Myocardial ecto-5'NT activity and adenosine release were increased after IP,but both were blunted by an inhibitor of ecto-5'NT (AMP-CP). The infarct size-limiting effect was also blunted by AMP-CP.Futhermore, transient administration (4 times of 5-min coronary infusion with a 5-min interval) of methoxamine (an stimulator of alpha 1-adrenoceptor) and PMA (an activator of PKC) mimicked the increase in ecto-5'NT activity and the infarct size-limiting effect after IP.Next, we tested the hypothesis that ischemic preconditining (IP) is attributable to activation of alpha-PKC.IP activated Ca^<2+>-dependent PKC of the membrane … More faction. Immunoblotting (IB) of the membrane fraction revealed the increases in the contents of alpha-PKC without changing the contents of beta-, delta-, and epsilon-PKC compared with the control myocardium. In the same membrane fractions, ecto-5'NT activity increased. And then, we examined whether PKC phospholylates ecto-5' T in the canine preconditioned myocardium. Immunoprecipitated ecto-5'NT was IB with antiphosphorylation antibodies. We observed the serine-theonine phosphorylation of immunoprecipitated ecto-5'NT due to the IP procedure. Futhermore, the increases in the activities of PKC and ecto-5'NT due to IP were blunted and the serine-threonine phosphorylation of immunoprecipitated ecto-5'NT was not detected by GY109203X (a specific inhibitor of protein kinase C). We conclude that ecto-5'NT in the myocardium is phosphorylated and activated by PKC in the IP to increase the adenosine relase. Activation of ecto-5'NT by phosphorylation is an important mechanism for cadioprotection in IP. Less
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
堀 正二: "Ischemic Preconditioningにおけるアデノシンの役割" 診断と新薬. 33(7). 1125-1127 (1996)
Shoji Hori:“腺苷在缺血预处理中的作用”诊断和新药 33(7) (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
堀 正二: "Ishemic Preconditioning" 77(6). 1215- (1996)
Shoji Hori:“缺血预处理”77(6)1215-(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
堀 正二: "目でみる冠動脈疾患の病態生理" メディカルレビュー社, 5-10 (1996)
Shoji Hori:“冠状动脉疾病的视觉病理生理学”医学评论出版,5-10(1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Cardiac stress-responsive mechanism and its theraprutic application
    • 批准号:
      11307013
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $5.76万
    • 财政年份:
      1999
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    Molecular epidemiology of acute coronary syndrome in Japan : Large-scale, prospective, multicenter clinical investigation
    • 批准号:
      11794035
    • 项目类别:
      Grant-in-Aid for University and Society Collaboration
    • 资助金额:
      $11.71万
    • 财政年份:
      1999
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    Prevention of atherosclerotic plaque rupture by the regulation of oxygen radical metabolism of vascular wall cells.
    • 批准号:
      10557071
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.64万
    • 财政年份:
      1998
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    Development of in vitro reconstituted system for investigating intracellular signal trasduction and cellular function in myocardial cells
    • 批准号:
      07557057
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $9.6万
    • 财政年份:
      1995
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    海外基金